Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Psyched Wellness ( (TSE:PSYC) ) has issued an update.
Psyched Wellness has entered into a non-binding term sheet with Gotham Green funds for a non-brokered private placement of common shares and warrants, aiming to raise up to C$1.72 million in two tranches, with the first tranche of about C$860,000 expected to close around March 18, 2026. The financing, priced below C$0.05 per security but cleared by the CSE, will be offered on a private basis in Canada and the U.S., support working capital needs, and includes an investor rights agreement that will give Gotham Green the ability to reshape the board through multiple director nominations, potentially strengthening its influence over the company’s strategic direction.
The placement structure, including long-dated warrants and optionality around the second tranche, reflects Psyched Wellness’s need for flexible capital while giving the investor group significant upside if the share price recovers. Board changes contemplated under the investor rights agreement mark a governance shift that could impact future strategy, execution priorities and stakeholder alignment as the company seeks to advance its Amanita-based wellness product portfolio in a competitive market.
The most recent analyst rating on (TSE:PSYC) stock is a Hold with a C$0.02 price target. To see the full list of analyst forecasts on Psyched Wellness stock, see the TSE:PSYC Stock Forecast page.
Spark’s Take on TSE:PSYC Stock
According to Spark, TipRanks’ AI Analyst, TSE:PSYC is a Neutral.
The score is held down primarily by heavy losses and ongoing cash burn despite strong revenue growth, with weak technical momentum adding pressure. A debt-free balance sheet and a positive product-related corporate update provide partial offsets, but valuation support is limited due to negative earnings and no dividend.
To see Spark’s full report on TSE:PSYC stock, click here.
More about Psyched Wellness
Psyched Wellness Ltd. is a life sciences company focused on producing and distributing health and wellness products derived from the Amanita Muscaria mushroom. The Toronto-based firm targets consumers seeking alternative, mushroom-based wellness solutions and is listed on the CSE, OTCQB and Frankfurt exchanges.
Average Trading Volume: 185,031
Technical Sentiment Signal: Sell
Current Market Cap: C$4.33M
For a thorough assessment of PSYC stock, go to TipRanks’ Stock Analysis page.